Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327979076> ?p ?o ?g. }
- W4327979076 abstract "Introduction In type 2 diabetes mellitus (T2DM), the antidiuretic system participates in the adaptation to osmotic diuresis further increasing urinary osmolality by reducing the electrolyte-free water clearance. Sodium glucose co-transporter type 2 inhibitors (SGLT2i) emphasize this mechanism, promoting persistent glycosuria and natriuresis, but also induce a greater reduction of interstitial fluids than traditional diuretics. The preservation of osmotic homeostasis is the main task of the antidiuretic system and, in turn, intracellular dehydration the main drive to vasopressin (AVP) secretion. Copeptin is a stable fragment of the AVP precursor co-secreted with AVP in an equimolar amount. Aim To investigate the copeptin adaptive response to SGLT2i, as well as the induced changes in body fluid distribution in T2DM patients. Methods The GliRACo study was a prospective, multicenter, observational research. Twenty-six consecutive adult patients with T2DM were recruited and randomly assigned to empagliflozin or dapagliflozin treatment. Copeptin, plasma renin activity, aldosterone and natriuretic peptides were evaluated at baseline (T0) and then 30 (T30) and 90 days (T90) after SGLT2i starting. Bioelectrical impedance vector analysis (BIVA) and ambulatory blood pressure monitoring were performed at T0 and T90. Results Among endocrine biomarkers, only copeptin increased at T30, showing subsequent stability (7.5 pmol/L at T0, 9.8 pmol/L at T30, 9.5 pmol/L at T90; p = 0.001). BIVA recorded an overall tendency to dehydration at T90 with a stable proportion between extra- and intracellular fluid volumes. Twelve patients (46.1%) had a BIVA overhydration pattern at baseline and 7 of them (58.3%) resolved this condition at T90. Total body water content, extra and intracellular fluid changes were significantly affected by the underlying overhydration condition ( p < 0.001), while copeptin did not. Conclusion In patients with T2DM, SGLT2i promote the release of AVP, thus compensating for persistent osmotic diuresis. This mainly occurs because of a proportional dehydration process between intra and extracellular fluid (i.e., intracellular dehydration rather than extracellular dehydration). The extent of fluid reduction, but not the copeptin response, is affected by the patient’s baseline volume conditions. Clinical trial registration Clinicaltrials.gov , identifier NCT03917758." @default.
- W4327979076 created "2023-03-21" @default.
- W4327979076 creator A5004767668 @default.
- W4327979076 creator A5007907892 @default.
- W4327979076 creator A5015238111 @default.
- W4327979076 creator A5028772304 @default.
- W4327979076 creator A5030232992 @default.
- W4327979076 creator A5032476232 @default.
- W4327979076 creator A5033129782 @default.
- W4327979076 creator A5033768482 @default.
- W4327979076 creator A5038835910 @default.
- W4327979076 creator A5057537921 @default.
- W4327979076 creator A5072698787 @default.
- W4327979076 creator A5073764611 @default.
- W4327979076 creator A5075034417 @default.
- W4327979076 creator A5076121607 @default.
- W4327979076 creator A5088611784 @default.
- W4327979076 creator A5091096322 @default.
- W4327979076 date "2023-03-20" @default.
- W4327979076 modified "2023-09-30" @default.
- W4327979076 title "Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study" @default.
- W4327979076 cites W1665634335 @default.
- W4327979076 cites W1975616172 @default.
- W4327979076 cites W1991337124 @default.
- W4327979076 cites W2024244915 @default.
- W4327979076 cites W2037060198 @default.
- W4327979076 cites W2041539328 @default.
- W4327979076 cites W2071788486 @default.
- W4327979076 cites W2086516175 @default.
- W4327979076 cites W2105820627 @default.
- W4327979076 cites W2122702020 @default.
- W4327979076 cites W2146264128 @default.
- W4327979076 cites W2153839551 @default.
- W4327979076 cites W2158575952 @default.
- W4327979076 cites W2410711024 @default.
- W4327979076 cites W2424539745 @default.
- W4327979076 cites W2606976824 @default.
- W4327979076 cites W2615515448 @default.
- W4327979076 cites W2626446274 @default.
- W4327979076 cites W2763866789 @default.
- W4327979076 cites W2792576512 @default.
- W4327979076 cites W2794339088 @default.
- W4327979076 cites W2800190471 @default.
- W4327979076 cites W2884835037 @default.
- W4327979076 cites W2898821382 @default.
- W4327979076 cites W2900413769 @default.
- W4327979076 cites W2923389432 @default.
- W4327979076 cites W2936022443 @default.
- W4327979076 cites W2947062659 @default.
- W4327979076 cites W2982430275 @default.
- W4327979076 cites W2993916007 @default.
- W4327979076 cites W3004975983 @default.
- W4327979076 cites W3014776907 @default.
- W4327979076 cites W3020930713 @default.
- W4327979076 cites W3091743373 @default.
- W4327979076 cites W3110105501 @default.
- W4327979076 cites W3177697454 @default.
- W4327979076 cites W4317478843 @default.
- W4327979076 cites W98167733 @default.
- W4327979076 doi "https://doi.org/10.3389/fnins.2023.1098404" @default.
- W4327979076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37021137" @default.
- W4327979076 hasPublicationYear "2023" @default.
- W4327979076 type Work @default.
- W4327979076 citedByCount "1" @default.
- W4327979076 countsByYear W43279790762023 @default.
- W4327979076 crossrefType "journal-article" @default.
- W4327979076 hasAuthorship W4327979076A5004767668 @default.
- W4327979076 hasAuthorship W4327979076A5007907892 @default.
- W4327979076 hasAuthorship W4327979076A5015238111 @default.
- W4327979076 hasAuthorship W4327979076A5028772304 @default.
- W4327979076 hasAuthorship W4327979076A5030232992 @default.
- W4327979076 hasAuthorship W4327979076A5032476232 @default.
- W4327979076 hasAuthorship W4327979076A5033129782 @default.
- W4327979076 hasAuthorship W4327979076A5033768482 @default.
- W4327979076 hasAuthorship W4327979076A5038835910 @default.
- W4327979076 hasAuthorship W4327979076A5057537921 @default.
- W4327979076 hasAuthorship W4327979076A5072698787 @default.
- W4327979076 hasAuthorship W4327979076A5073764611 @default.
- W4327979076 hasAuthorship W4327979076A5075034417 @default.
- W4327979076 hasAuthorship W4327979076A5076121607 @default.
- W4327979076 hasAuthorship W4327979076A5088611784 @default.
- W4327979076 hasAuthorship W4327979076A5091096322 @default.
- W4327979076 hasBestOaLocation W43279790761 @default.
- W4327979076 hasConcept C126322002 @default.
- W4327979076 hasConcept C134018914 @default.
- W4327979076 hasConcept C2776370428 @default.
- W4327979076 hasConcept C2777180221 @default.
- W4327979076 hasConcept C2777422806 @default.
- W4327979076 hasConcept C2779311642 @default.
- W4327979076 hasConcept C2780221984 @default.
- W4327979076 hasConcept C2781214132 @default.
- W4327979076 hasConcept C2910068830 @default.
- W4327979076 hasConcept C33872192 @default.
- W4327979076 hasConcept C555293320 @default.
- W4327979076 hasConcept C71924100 @default.
- W4327979076 hasConceptScore W4327979076C126322002 @default.
- W4327979076 hasConceptScore W4327979076C134018914 @default.
- W4327979076 hasConceptScore W4327979076C2776370428 @default.
- W4327979076 hasConceptScore W4327979076C2777180221 @default.
- W4327979076 hasConceptScore W4327979076C2777422806 @default.